Lv61
2360 积分 2023-08-16 加入
Adalimumab for the treatment of Crohn’s disease
2小时前
已完结
Adalimumab for the treatment of Crohn’s disease
2小时前
已关闭
Adalimumab for the treatment of Crohn’s disease
2小时前
已关闭
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
28天前
已完结
Clinical characteristics and quality of life in patients with inflammatory bowel disease-associated anemia in Southeast China
2个月前
已完结
Comprehensive overview of novel chemical drugs for ulcerative colitis: focusing on phase 3 and beyond
5个月前
已完结
CC-10004
6个月前
已关闭
Development and Subsequent Refinement of the Inflammatory Bowel Disease Questionnaire: A Quality-of-Life Instrument for Adult Patients with Inflammatory Bowel Disease
6个月前
已完结
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval
1年前
已完结
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
1年前
已完结
皖公网安备34019202002308
